… Accordingly, anti-TNF drugs are still classified by the FDA as “pregnancy risk category B”,
as human studies are still insufficient to guarantee their safety for the foetus although no …

Objective Tuberculosis (TB) is associated with anti–tumor necrosis factor (anti‐TNF) monoclonal
antibody (mAb) therapy, but whether this association is drug‐specific remains a concern…

… B cells play a multifaceted role, acting as antigen-presenting cells and producing pathogenic
autoantibodies, cytokines, and chemokines, which supports the use of B cell depletion …

Objective. The objective of this study was to identify predictors of response and remission to
tocilizumab (TCZ) in RA patients seen in daily routine clinical practice. Methods. The efficacy …

The goal of the present study was to record changes in bone mineral density (BMD) and
markers of bone turnover in patients with rheumatoid arthritis (RA) who were treated with …

… of neutropenia after RTX in B-cell lymphoma, including … B-cell activating factor of the tumour
necrosis factor (TNF) family (BAFF) after B-cell depletion might also play a role by favouring B…

… Relative peak intensities of the 7769 Da (A) the 8210 (B) and the 27 976 Da biomarkers in
the responder (R) and non-responder (NR) populations. The box represents the interquartile …

Objective. To assess the relationship between the body mass index (BMI) and the efficacy of
tocilizumab (TCZ) in patients with rheumatoid arthritis (RA). Methods. We conducted a …

… -B were polymerase chain reaction (PCR) amplified using a combination of DR specific and
B … For the B specific primer the sequences were: forward primer, 5′GGG AGG AGC GAG …

The clinical presentation and outcome of hepatitis E virus (HEV) infection in inflammatory
rheumatic diseases are unknown. We aimed to investigate the severity of acute HEV infection …